12:00 AM
 | 
Oct 18, 1999
 |  BC Week In Review  |  Company News  |  Deals

AltaRex Corp., Purdue Pharma deal

Purdue will not exercise its option under the companies' May agreement to exclusively license AXO's OvaRex and BrevaRex...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >